Analyte Specific Reagent. Analytical and performance characteristics are not established.
- Clone
- Ber-ACT35 (ACT35)
- Other Names
- ACT35 antigen, tumor necrosis factor receptor superfamily member 4 (TNFRSF4)
- Isotype
- Mouse IgG1, κ
Cat # | Size | Price | Quantity Check Availability | Save | ||
---|---|---|---|---|---|---|
981502 | 500 µL | $322 |
CD134, also known as OX40 and TNFRSF4, is a 50 kD type I transmembrane glycoprotein. It is a member of the TNF receptor superfamily. OX40 is expressed on activated T lymphocytes including Th1, Th2, Th17, and Treg cells. The interaction of OX40 with OX40L results in B cell proliferation and antibody secretion, regulation of primary T cell expansion, and T cell survival. OX40 influences the size of the T cell memory pool and regulation of CD4+ T cell tolerance.
Product DetailsProduct Details
- Reactivity
- Human
- Formulation
- Phosphate-buffered solution, pH7.2, 0.09% sodium azide, 0.2% (w/v) BSA (origin USA), and a stabilizer.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- 200 µg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
Suggested for Flow Cytometry
- Disclaimer
-
WARNINGS AND PRECAUTIONS
- Use appropriate personal protective equipment and safety practices per universal precautions when working with this reagent. Refer to the reagent safety data sheet.
- This antibody contains sodium azide. Follow federal, state and local regulations to dispose of this reagent. Sodium azide build-up in metal wastepipes may lead to explosive conditions; if disposing of reagent down wastepipes, flush with water after disposal.
- All specimens, samples and any material coming in contact with them should be considered potentially infectious and should be disposed of with proper precautions and in accordance with federal, state and local regulations.
- Do not use this reagent beyond the expiration date stated on the label.
- Do not use this reagent if it appears cloudy or if there is any change in the appearance of the reagent as these may be an indication of possible deterioration.
- Avoid prolonged exposure of the reagent or stained cells to light.
Antigen Details
- Antigen References
-
- Smith CA, et al. 1994. Cell. 76:959.
- Chen AL, et al. 1999. Immunity. 11:689.
- Croft M. 2010. Annu. Rev. Immunol. 28:57.
- Withers DR, et al. 2009. J. Immunol. 183:5079.
- Klinger M, et al. 2009. J. Immunol. 182:4581.
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
-
FITC anti-human CD134 (OX40)
Human peripheral blood lymphocytes were activated for 3 days... -
Purified anti-human CD134 (OX40)
PHA-stimulated (3 days) human peripheral blood lymphocytes w... Formalin-fixed paraffin-embedded human tonsil treated with a... -
PE anti-human CD134 (OX40)
3-day PHA-activated human peripheral blood lymphocytes were ... -
APC anti-human CD134 (OX40)
Human peripheral blood lymphocytes were activated for 3 days... -
PerCP/Cyanine5.5 anti-human CD134 (OX40)
Human peripheral blood lymphocytes were activated for 3 days... -
PE/Cyanine7 anti-human CD134 (OX40)
PHA-stimulated (3 days) human peripheral blood lymphocytes w... -
Brilliant Violet 421™ anti-human CD134 (OX40)
PHA-stimulated (3-days) human peripheral blood lymphocytes w... -
Purified anti-human CD134 (OX40) (Maxpar® Ready)
Human PBMCs were incubated for 3 days in media alone (top) o... -
Alexa Fluor® 647 anti-human CD134 (OX40)
PHA-stimulated (3 days) human peripheral blood lymphocytes w... -
PE/Dazzle™ 594 anti-human CD134 (OX40)
PHA-stimulated (3 days) human peripheral blood lymphocytes w... -
APC/Cyanine7 anti-human CD134 (OX40)
PHA-stimulated (3 days) human peripheral blood lymphocytes w... -
Biotin anti-human CD134 (OX40)
PHA-stimulated (3 days) human peripheral blood lymphocytes w... -
Brilliant Violet 510™ anti-human CD134 (OX40)
PHA-stimulated (3 days) human peripheral blood lymphocytes w... -
Brilliant Violet 605™ anti-human CD134 (OX40)
PHA-stimulated (3 days) human peripheral blood lymphocytes w... -
APC/Fire™ 750 anti-human CD134 (OX40)
PHA-stimulated (3 days) human peripheral blood lymphocytes w... -
Brilliant Violet 711™ anti-human CD134 (OX40)
PHA-stimulated (3 days) human peripheral blood lymphocytes w... -
TotalSeq™-A0158 anti-human CD134 (OX40)
-
TotalSeq™-C0158 anti-human CD134 (OX40)
-
TotalSeq™-B0158 anti-human CD134 (OX40)
-
TotalSeq™-D0158 anti-human CD134 (OX40)
-
PE/Cyanine5 anti-human CD134 (OX40)
PHA-stimulated (3 days) human peripheral blood lymphocytes w... -
PE/Fire™ 810 anti-human CD134 (OX40)
Human peripheral blood lymphocytes were activated for 3 days... -
PE anti-human CD134
Typical result from PHA-stimulated (3 days) human peripheral... -
PE/Fire™ 744 anti-human CD134 (OX40)
PHA-stimulated (three days) human peripheral blood lymphocyt... -
Brilliant Violet 785™ anti-human CD134 (OX40)
PHA-stimulated (3 days) human peripheral blood lymphocytes w... -
Brilliant Violet 650™ anti-human CD134 (OX40)
PHA-stimulated (3-days) human peripheral blood lymphocytes w...
Follow Us